fbpx

YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

VP Watchlist

The VP Watchlist contains current coverage companies that deserve consideration for short term and long term portfolio additions.

Latest News

  Shares of Indaptus Therapeutics, Inc. (Nasdaq: INDP) closed at $2.30 on Monday, May 20, 2024. Indaptus is a company with the ability to harness both the body’s innate and adaptive immune...

Read More

According to the American Cancer Society, lung cancer is the second leading cause of cancer in the US, with over 200,000 patients diagnosed annually. Historically, never smokers with NSCLC make up abo...

Read More

Indaptus Therapeutics (NASDAQ: INDP) has evolved from more than a century of immunotherapy advances. The Company’s novel approach is based on the hypothesis that efficient activation of both innate ...

Read More

Vista Research

Blog & Newsletters

Exclusive daily market recaps & stories, weekly market views, and macroeconomic and investment newsletters help investors to stay current with real-time market coverage that is sent FREE directly to all that are in the Vista Network.

Learn More

Interviews

"Vista’s “Interviews Page” provides consolidated access to our sister organization Tribe Public’s Presentation and Q&A Event Webinar Series & other exciting interviews from other organizations that we would like to highlight from around the world."

Learn More

YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us